School of Chemical and Biomedical Engineering, Nanyang Technological University, 62 Nanyang Drive, Singapore 637459.
Biomaterials. 2010 Aug;31(24):6228-38. doi: 10.1016/j.biomaterials.2010.04.059. Epub 2010 May 26.
Vascular smooth muscle cells (vSMCs) cultured in vitro are known to exhibit phenotype hyperplasticity. This plasticity is potentially very useful in tissue engineering of blood vessels. The synthetic phenotype is necessary for cell proliferation on the tissue scaffold but the cells must ultimately assume a quiescent, contractile phenotype for normal vascular function. In vitro control of vSMC phenotype has been challenging. This study shows that microchannel scaffolds with discontinuous walls can support primary vSMC proliferation and, when the cells reach confluence inside the channels, transform the cell phenotype towards greater contractility and promote cell alignment. A thorough time-resolved study was undertaken to characterize the expression of the contractile proteins alpha-actin, calponin, myosin heavy chain (MHC) and smoothelin as a function of time and initial cell density on microchannel scaffolds. The results consistently indicate that primary vSMCs cultured on the microchannel substrate substantially align parallel to the microwalls, become more elongated and significantly increase their expression of contractile proteins only when the cells reach confluence. MHC immunostaining was visible in the micropatterned cells after confluence but not in flat substrate cells or non-confluent micropatterned cells, which further verifies the increased contractility of the confluent channel-constrained vSMCs. The higher total amount of deposited elastin and collagen in confluent flat cultures than in confluent micropatterned cultures also provides confirmation of the higher contractility of the channel-constrained cells. These results establish that our microchanneled film can trigger the switch of primary vSMCs from a proliferative state to a more contractile phenotype at confluence.
体外培养的血管平滑肌细胞(vSMCs)表现出表型增生性。这种可塑性在血管组织工程中具有潜在的非常有用。合成表型对于细胞在组织支架上的增殖是必要的,但细胞最终必须表现出静止、收缩的表型,以维持正常的血管功能。体外控制 vSMC 表型一直具有挑战性。本研究表明,具有不连续壁的微通道支架可以支持原代 vSMC 的增殖,并且当细胞在通道内达到汇合时,将细胞表型向更高的收缩性转变,并促进细胞排列。进行了一项彻底的时间分辨研究,以研究收缩蛋白α-肌动蛋白、钙调蛋白、肌球蛋白重链(MHC)和 smoothelin 的表达作为时间和初始细胞密度的函数,在微通道支架上。结果一致表明,在微通道基质上培养的原代 vSMCs 与微壁基本平行排列,变得更加细长,并且仅当细胞达到汇合时,才会显著增加收缩蛋白的表达。MHC 免疫染色在汇合后的微图案化细胞中可见,但在平面基质细胞或非汇合的微图案化细胞中不可见,这进一步验证了汇合的通道约束 vSMCs 的收缩性增加。在汇合的平面培养物中沉积的弹性蛋白和胶原蛋白总量高于汇合的微图案化培养物,这也证实了通道约束细胞的收缩性更高。这些结果表明,我们的微通道膜可以触发原代 vSMCs 从增殖状态向更高收缩性表型的转变。